Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Borchmann

Showing results (31-40 of 252) with videos related to

Pageof 26
Sort By:
Current Hematologic Malignancy Reports|May 10, 2011
The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphomaTeresa V Halbsguth, Boris Böll, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adultsMarkus Schaaf, Marcel Reiser, Peter Borchmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2020
Reply to H.J.A. Adams et alMichael Fuchs, Helen Goergen, Carsten Kobe, et al.
Deutsches Arzteblatt International|March 21, 2023
Diffuse Large B-Cell Lymphoma and Related EntitiesMoritz Ernst, Ulrich Dührsen, Dirk Hellwig, et al.
Haematologica|November 13, 2008
Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemiaThomas Elter, Julia Kilp, Peter Borchmann, et al.
Journal of the National Cancer Institute|July 16, 2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 5, 2020
The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivorsNele Stadtbaeumer, Horst Müller, Helen Goergen, et al.
Journal of the National Cancer Institute|July 18, 2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Deutsches Arzteblatt International|February 2, 2013
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaBeate Klimm, Corinne Brillant, Nicole Skoetz, et al.
Leukemia Research|September 7, 2014
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomasChristian Gisselbrecht, Peter Borchmann, Francesco D'Amore, et al.
Pageof 26

Showing results (31-40 of 252) with videos related to

Sort By:
Pageof 26
Current Hematologic Malignancy Reports|May 10, 2011
The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphomaTeresa V Halbsguth, Boris Böll, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adultsMarkus Schaaf, Marcel Reiser, Peter Borchmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2020
Reply to H.J.A. Adams et alMichael Fuchs, Helen Goergen, Carsten Kobe, et al.
Deutsches Arzteblatt International|March 21, 2023
Diffuse Large B-Cell Lymphoma and Related EntitiesMoritz Ernst, Ulrich Dührsen, Dirk Hellwig, et al.
Haematologica|November 13, 2008
Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemiaThomas Elter, Julia Kilp, Peter Borchmann, et al.
Journal of the National Cancer Institute|July 16, 2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 5, 2020
The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivorsNele Stadtbaeumer, Horst Müller, Helen Goergen, et al.
Journal of the National Cancer Institute|July 18, 2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Deutsches Arzteblatt International|February 2, 2013
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaBeate Klimm, Corinne Brillant, Nicole Skoetz, et al.
Leukemia Research|September 7, 2014
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomasChristian Gisselbrecht, Peter Borchmann, Francesco D'Amore, et al.
Pageof 26